Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Doxazosin may cause breast enlargement and pain in men.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Strontium ranelate is no longer available for treatment.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Individualized treatments may help manage Dercum's disease symptoms.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Etanercept may cause hair fragility and breakage.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.